The not-so-simple HDL story

A new era for quantifying HDL and cardiovascular risk?

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Overview of reverse cholesterol transport by HDL.


  1. 1

    Rader, D.R. & Tall, A.R. Nat. Med. 18, 1344–1346 (2012).

    CAS  Article  Google Scholar 

  2. 2

    Tall, A.R., Yvan-Charvet, L., Terasaka, N., Pagler, T. & Wang, N. Cell Metab. 7, 365–375 (2008).

    CAS  Article  Google Scholar 

  3. 3

    Bérard, A.M. et al. Nat. Med. 3, 744–749 (1997).

    Article  Google Scholar 

  4. 4

    Trigatti, B. et al. Proc. Natl. Acad. Sci. USA 96, 9322–9327 (1999).

    CAS  Article  Google Scholar 

  5. 5

    de la Llera-Moya, M. et al. Arterioscler. Thromb. Vasc. Biol. 30, 796–801 (2010).

    CAS  Article  Google Scholar 

  6. 6

    Khera, A.V. et al. N. Engl. J. Med. 364, 127–135 (2011).

    CAS  Article  Google Scholar 

  7. 7

    Rosenson, R.S. et al. Clin. Chem. 57, 392–410 (2001).

    Article  Google Scholar 

  8. 8

    Vaisar, T. et al. J. Clin. Invest. 117, 746–756 (2007).

    CAS  Article  Google Scholar 

  9. 9

    Mackey, R.H. et al. J. Am. Coll. Cardiol. 60, 508–516 (2012).

    CAS  Article  Google Scholar 

  10. 10

    Green, P.S. et al. Circulation 118, 1259–1267 (2008).

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Jay W Heinecke.

Ethics declarations

Competing interests

J.W.H. receives research support from Merck, GlaxoSmithKline and Bristol-Myers Squibb.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Heinecke, J. A new era for quantifying HDL and cardiovascular risk?. Nat Med 18, 1346–1347 (2012).

Download citation

Further reading


Quick links

Sign up for the Nature Briefing newsletter for a daily update on COVID-19 science.
Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing